Search Within

Tania Jain

Formats
  1. Journal Article (13)
  2. Meeting Abstract (12)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. MSK Grad Students (27)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Hematologic Malignancies, Division of (17)
  5. Bone Marrow Transplant (16)
  6. CTCR Scholars (13)

More Groups

People
  1. Miguel-Angel Perales (15)
  2. Molly Maloy (11)
  3. Sergio Giralt (11)
  4. Craig Sauter (10)
  5. Gunjan Shah (10)
  6. Michael Scordo (10)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2020 (8)
  4. 2019 (11)
  5. 2018 (5)
Publications
  1. Biology of Blood and Marrow Transplantation (9)
  2. Blood (6)
  3. Blood Advances (6)
  4. Case Reports in Hematology (1)
  5. Hematologic Malignancies (1)
  6. Hematology-American Society of Hematology Education Program (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Elsevier Inc. (9)
  3. American Society for Clinical Investigation (1)
  4. Hindawi Ltd (1)
  5. Nature Publishing Group (1)
  6. Royal Society (1)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparing CAR T-cell toxicity grading systems: Application of the ASTCT grading system and implications for management
    Journal Article

    Pennisi, M.; Jain, T.; Santomasso, B. D.; Mead, E.; Wudhikarn, K.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Comparing gradings of immune effector cells toxicities: Application of ASTCT consensus grading system and implications for clinical management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells
    Meeting Abstract

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J.; Maloy, M. A.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Devlin, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Hematological count recovery in patients undergoing treatment with chimeric antigen receptor T cells (CAR T)
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Maloy, M. A.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Clinical outcomes of matched unrelated allogeneic stem cell transplant patients: Low dose ATG vs. no ATG
    Meeting Abstract

    Mountjoy, L.; Kunze, K. L.; Jain, T.; Slack, J. L.; Khera, N.; Leis, J. F.; Noel, P.; Sproat, L. Z.; Palmer, J.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Cytomegalovirus reactivation promotes CD8+ T cell subset recovery after unmodified allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Jain, T.; Cho, C.; Hilden, P.; Politikos, I.; Borrill, T.; Giralt, S. A.; Maslak, P.; O'Reilly, R. J.; van den Brink, M. R. M.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Do cytogenetics predict likelihood to attain minimal residual disease (MRD) post autologous stem cell transplantation (SCT) in multiple myeloma (MM)?
    Meeting Abstract

    Jain, T.; Guerrero, C.; Kosiorek, H.; Butterfield, R.; Mountjoy, L.; Reeder, C.; Bergsagel, P. L.; Larsen, J. T.; Stewart, K.; Fonseca, R.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic stem cell therapy in relapsed/refractory B cell lymphomas
    Meeting Abstract

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: An expert panel opinion from the American Society for Transplantation and Cellular Therapy
    Guidelines

    Jain, T.; Bar, M.; Kansagra, A. J.; Chong, E. A.; Hashmi, S. K.; Neelapu, S. S.; Byrne, M.; Jacoby, E.; Lazaryan, A.; Jacobson, C. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/refractory B cell non-Hodgkin lymphoma
    Journal Article

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Leukemia (2019)

    Fulltext@MSK | Save